BOSTON & MONTREAL, June 25, 2025--enGene Holdings Inc. (Nasdaq: ENGN, or "enGene" or the "Company"), a clinical-stage, ...

Scientists found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.

Bladder cancer can be a silent killer, often presenting few symptoms in its early stages. Learn about the disease, its early symptoms, and more.

CAR-T therapy targeting TM4SF1 in aggressive bladder cancer (HV) histologic variant , offering hope for treatment-resistant ...

With topical estrogen, the vaginal flora returns back to the premenopausal stage with less E. coli -- a common cause of ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...

DelveInsight's, “Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ ...

New research reveals that Gαi3 is overexpressed in bladder cancer and promotes tumour growth via the Akt-mTOR pathway, ...

Bladder cancer is actually the 10th most common cancer worldwide but sixth in men, whereas it is three times as common as in ...